June 20, 2023 The Test Wisely transparency survey was received June 1st, 2023. As promised, as of today, June 20th, 2023, updates on the labs that have responded to CGI are as follows: Communication Received that the Laboratory is Working on Completing the Survey...
Surveys sent to 11 major labs to facilitate comparison of similarities and differences between test options SANDY, UT, USA, June 15, 2023/EINPresswire.com/ — At the end of May, a transparency survey was sent to the CEOs of eleven major clinical laboratories requesting...
Wharf to Provide Clinical Expertise on ELEVATEGENETICS services and Large Research ProjectsSalt Lake, UT / PRWeb / May 8, 2023 – Bryan Warf, PhD has joined the Center for GenomicInterpretation (CGI) as the 501(c)(3) nonprofit’s Senior Director of Scientific Affairs....
Access to guideline recommended biomarker testing continues to vary depending on the insurance payer and also from state to state. Legislation is passing in many states to guarantee insurance coverage of biomarker testing. This testing, if accurate, helps determine...
Sandy, UT / EIN Newswire / March 21, 2023 – The independent and nonprofit Center for Genomic Interpretation’s (CGI) is launching ELEVATEGENETICS VERIFY™, which is part of the ELEVATEGENETICS® suite of services. The new CGI VERIFY Program helps analyze laboratory...
PROBLEM: A government convened workgroup discovered that CLIA mandated proficiency testing is “too easy“. As a result, too many low quality labs with both CLIA & CAP accreditation are issuing too many inaccurate genetic & genomic test results, which are...
The post Center For Genomic Interpretation Seeks Nominations of ELEVATEGENETICS Acceptable Thresholds Committee appeared first on Center for Genomic Interpretation. The post Center For Genomic Interpretation Seeks Nominations of ELEVATEGENETICS Acceptable Thresholds...
Problem: Many clinical genetic and genomic labs knowingly or unknowingly take inappropriate shortcuts that may ultimately lead to mistakes in their test validations. These ‘mistakes’ can impact patient care and outcomes. With LDTs not being regulated, they can go...
An article recently published in Nature discusses a legal case in which a #cardiology#genemutation classification has been evaluated by 2 expert groups. The stakes of an accurate classification are high since they impact the freedom or continued incarceration of a...
“According to the Centers for Disease Control and Prevention, 70% of health care decisions are based on clinical lab tests. The potential for the future is even greater, with early detection and better treatment guidance, and opportunities for new targeted therapies...